HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
暂无分享,去创建一个
Joseph G. Jardine | Oleksandr Kalyuzhniy | Yumiko Adachi | William R. Schief | Fabian Sesterhenn | Xiaozhen Hu | Dennis R. Burton | Ian A. Wilson | Bryan Briney | Anita Sarkar | Michael Kubitz | Daniel W. Kulp | Allan C. deCamp | June Ereño-Orbea | Xiaozhen Hu | D. Burton | I. Wilson | W. Schief | B. Briney | J. Jardine | O. Kalyuzhniy | Yumiko Adachi | J. Julien | S. Crotty | D. Sok | Meaghan Jones | D. Kulp | C. Havenar-Daughton | Shane Crotty | Devin Sok | Erik Georgeson | Erik Georgeson | M. Kubitz | A. Sarkar | F. Sesterhenn | J. Ereño-Orbea | Isaiah Deresa | S. Spencer | Jean-Philippe Julien | Meaghan Jones | Colin Havenar-Daughton | Skye Spencer | Isaiah Deresa
[1] Cinque S. Soto,et al. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors , 2015, Cell.
[2] Dmitrij Frishman,et al. STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..
[3] Chaim A. Schramm,et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies , 2014, Nature.
[4] Martin Phillips,et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[6] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[7] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[8] Timothy A. Whitehead,et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing , 2012, Nature Biotechnology.
[9] Ron Diskin,et al. Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design , 2011, Science.
[10] J. Mascola,et al. HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins , 2012, Journal of Virology.
[11] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[12] J. Liese,et al. Reference values for B cell subpopulations from infancy to adulthood , 2010, Clinical and experimental immunology.
[13] David Nemazee,et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen , 2015, Science.
[14] Ron Diskin,et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.
[15] Michel C Nussenzweig,et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.
[16] L. Stamatatos,et al. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies , 2013, The Journal of experimental medicine.
[17] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[18] George Georgiou,et al. In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire , 2014, Nature Medicine.
[19] Young Do Kwon,et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. , 2013, Immunity.
[20] M. Nussenzweig,et al. Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120 , 2012, Retrovirology.
[21] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[22] M. Shlomchik,et al. Very Low Affinity B Cells Form Germinal Centers, Become Memory B Cells, and Participate in Secondary Immune Responses When Higher Affinity Competition Is Reduced , 2002, The Journal of experimental medicine.
[23] Ron Diskin,et al. Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies , 2013, The Journal of experimental medicine.
[24] John R Mascola,et al. Antibody responses to envelope glycoproteins in HIV-1 infection , 2015, Nature Immunology.
[25] Tongqing Zhou,et al. Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization , 2013, Science.
[26] Ron Diskin,et al. Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 , 2012, Proceedings of the National Academy of Sciences.
[27] Randy J. Read,et al. Phenix - a comprehensive python-based system for macromolecular structure solution , 2012 .
[28] Andreas Radbruch,et al. Generation of stable monoclonal antibody-producing BCR+ human memory B cells by genetic programming , 2009, Nature Medicine.
[29] David Nemazee,et al. Rational immunogen design to target specific germline B cell receptors , 2012, Retrovirology.
[30] Daniel W. Kulp,et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice , 2015, Cell.
[31] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[32] M. Nussenzweig,et al. Role of BCR affinity in T cell–dependent antibody responses in vivo , 2002, Nature Immunology.
[33] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.